Tatyana A Sysoeva

Dr. Tatyana A Sysoeva


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2016 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
ALAllison J. Lopatkin
Allison J. Lopatkin
SHShuqiang Huang
Shuqiang Huang
RSRobert P. Smith
Robert P. Smith
JSJaydeep K. Srimani
Jaydeep K. Srimani
TSTatyana A Sysoeva
Tatyana A Sysoeva
LYLingchong You
Lingchong You

14 May 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
TSTatyana A Sysoeva
Tatyana A Sysoeva
MZMartha A. Zepeda-Rivera
Martha A. Zepeda-Rivera
LHLaura A. Huppert
Laura A. Huppert
BBBriana M. Burton
Briana M. Burton
Significance: Bacteria use a wide range of secretion mechanisms to export proteins from the cytoplasm. These secretion pathways differ in the nature of substrate recognition signal and the mode of substrate translocation. This work elucidates fundamental properties of substrate secretion by the early secretory antigen 6 kDa (ESX) system. We use systematic mutagenesis and targeted crosslinking of an ESX substrate fromBacillus subtilisto provide, to our knowledge, the first experimental evidence for secretion of an intact dimeric complex requiring a composite recognition signal formed by both members of the complex.

16 September 2019 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ZDZhuojun Dai
Zhuojun Dai
ALAnna J. Lee
Anna J. Lee
SRStefan Roberts
Stefan Roberts
TSTatyana A Sysoeva
Tatyana A Sysoeva
SHShuqiang Huang
Shuqiang Huang
LYLingchong You
Lingchong You

16 December 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
Kui ZhuKui Zhu
Kui Zhu
SCShang Chen
Shang Chen
TSTatyana A Sysoeva
Tatyana A Sysoeva
LYLingchong You
Lingchong You
Pseudomonas aeruginosa is an opportunistic pathogen that often infects open wounds or patients with cystic fibrosis. Once established, P. aeruginosa infections are notoriously difficult to eradicate. This difficulty is in part due to the ability of P. aeruginosa to tolerate antibiotic treatment at the individual-cell level or through collective behaviors. Here, we describe a new phenomenon by which P. aeruginosa tolerates antibiotic treatment. In particular, treatment of P. aeruginosa with sublethal concentrations of antibiotics covering all major classes promoted accumulation of the redox-sensitive phenazine pyocyanin (PYO). PYO in turn conferred general tolerance against diverse antibiotics for both P. aeruginosa and other gram-negative and gram-positive bacteria. This property is shared by other redox-active phenazines produced by P. aeruginosa. Our discovery sheds new insights into the physiological functions of phenazines and has implications for designing effective antibiotic treatment protocols.

4 October 2016 in BioEssays
Verified
Journal Article
Closed access
PDF file
ALAllison J. Lopatkin
Allison J. Lopatkin
TSTatyana A Sysoeva
Tatyana A Sysoeva
LYLingchong You
Lingchong You

1 November 2010 in Structure
Verified
Journal Article
Closed access
BCBaoyu Chen
Baoyu Chen
TSTatyana A Sysoeva
Tatyana A Sysoeva
SCSaikat Chowdhury
Saikat Chowdhury
LGLiang Guo
Liang Guo
SCSacha De Carlo
Sacha De Carlo
BNB. Tracy Nixon
B. Tracy Nixon